RH Capital is an impact-first venture capital fund of Rhia Ventures that invests in early-stage startups revolutionizing women's health, with a focus on reproductive and maternal health equity in the United States. The firm is female-led and primarily backs women and BIPOC founders.
67% of their portfolio is in Healthcare. Their most common stage is series-a (56% of deals). Average disclosed round size is $13.4M (across 6 rounds with reported amounts).
Portfolio
9
Fund Size
$38.5M
Top Stage
Series A
Last 12 Mo
1
Team
AS
Anton Suprun
Managing Director, Capital Markets
EB
Elizabeth Bailey
Managing Director
SO
Stasia Obremskey
Managing Director
EC
Edison Chen
Executive Director
HJ
Haley John
Founder and Managing Principal
KQ
Kevin Qin
Principal
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
9 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Nadia | Unknown | $12M | Mar 2026 |
 Twentyeight Health | Series A | — | Jan 2025 |
 Raydiant Oximetry | Series A | $7.5M | Jun 2024 |
 Evvy | Series A | — | Sep 2023 |
 Eli Health | Seed | — | Apr 2023 |
 Cayaba Care | Series A | $12M | Jun 2022 |
| TTestmate Health | Seed | $6M | — |
| AAOA | Unknown | $17M | — |
| NNovocuff | Series A | $26M | — |
Top Co-Investors
SE Ventures2 shared
Kapor Capital2 shared
Labcorp2 shared
Amboy Street Ventures2 shared
The Helm2 shared
Charge Ventures1 shared
Muse Capital1 shared
Impact Engine1 shared
Impact America Fund1 shared
Gratitude Railroad1 shared
Left Lane Capital1 shared
Virtue1 shared
G9 Ventures1 shared
General Catalyst1 shared
Ingeborg Investments1 shared
Cross-Border Impact Ventures1 shared
First Trust Capital Partners1 shared
Valtruis1 shared
Zürcher Kantonalbank1 shared
Last updated: 14 September 2026